|
0
|
|
Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/beta-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.
(journals.asm.org)
|
Perez-Rodriguez G
…
Arca-Suarez J
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#genomics
#amr
#plasmid
#outbreak
|
|
0
|
|
Prevalence and genetics of cefepime resistance among the AmpC-producing organisms Citrobacter freundii complex, Enterobacter cloacae complex, and Klebsiella aerogenes.
(journals.asm.org)
|
Schrader SM
…
Pecora ND
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#genomics
#infection
#amr
|
|
0
|
|
Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC.
(journals.asm.org)
|
Krankel L
…
Slavetinsky C
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#genomics
#amr
#virulence
#evolution
#sepsis
|
|
0
|
|
Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant Escherichia coli.
(journals.asm.org)
|
Shropshire WC
…
Shelburne S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#genomics
#infection
#amr
#sequencing
#plasmid
|
|
0
|
|
A novel bile salt hydrolase-producing Ligilactobacillus salivarius prevents diet-induced obesity via regulation of bile acid metabolism and glucagon-like peptide 1 restoration.
(tandfonline.com)
|
Lv J
…
Shi L
Gut Microbes
2026-05-06
|
#microbiome
#genomics
#metabolism
#probiotic
#obesity
|